Skip to main content
Fig. 3 | COPD Research and Practice

Fig. 3

From: Altered antioxidant enzyme activity with severity and comorbidities of chronic obstructive pulmonary disease (COPD) in South Indian population

Fig. 3

Antioxidant enzyme activities in COPD patients with T2D, PHT and CVD and compared with the healthy controls. Erythrocytes (a) SOD, superoxide dismutase; b CAT, catalase; c GST, glutathione-s-transferase; d GPx, glutathione peroxidase; e GR, glutathione reductase; expressed as U/mg protein and (f) TAS, total antioxidant status; expressed as μM Fe2+/l. Data expressed as Mean ± SEM: standard error of the mean; Significance of difference between COPD and type 2 diabetes (T2D), pulmonary hypertension (PHT) and cardiovascular disease (CVD) to control: Significant differences and respective p values *p < 0.05, **p < 0.001 are mentioned on the graph using one-way ANOVA followed by Bonferroni’s multiple comparison post hoc test

Back to article page